{"ticker":"ARWR","companyName":"ARROWHEAD PHARMACEUTICALS, INC.","fiscalYear":2025,"executiveName":"Christopher Anzalone","executiveTitle":"President and Chief Executive Officer","totalComp":9029861,"salary":981046,"stockAwards":6810292,"nonEquityIncentive":1236000,"otherComp":2523,"yoyChangePct":-27.316129716706435,"source":{"filingType":"DEF 14A","accession":"0000879407-26-000019","filingDate":"2026-01-27","filingUrl":"https://www.sec.gov/Archives/edgar/data/879407/000087940726000019/arwr-20260126.htm"},"lastUpdated":"2026-06-25T08:10:31.479Z","yoy_total_comp_pct":-27.316129716706435}